Ultralow-Dose Adjunctive Methadone with Slow Titration, Considering Long Half-Life, for Outpatients with Cancer-Related Pain

Ultralow-Dose Adjunctive Methadone with Slow Titration, Considering Long Half-Life, for Outpatients with Cancer-Related Pain

Background: The unique properties of methadone make it attractive for use in cancer pain. The use of very low initial doses of adjunctive methadone is a promising strategy given its simplicity and potentially reduced risk profile. Objective: To understand if an ultralow-dose (ULD) methadone protocol...

Full description

Bibliographic Details
Main Authors: Srini Chary, Amane Abdul-Razzak, Lyle Galloway
Format: Article
Language:English
Published: Mary Ann Liebert 2020-07-01
Series:Palliative Medicine Reports
Subjects:
analgesia
cancer pain
methadone
pain
palliative care
Online Access:https://www.liebertpub.com/doi/full/10.1089/PMR.2020.0034

Internet

https://www.liebertpub.com/doi/full/10.1089/PMR.2020.0034

Similar Items